In Reply To determine the use of stem cell transplant worldwide, we cited prior data published by the World Bone Marrow Transplant network,1 which did not include transplant rates for Taiwan. We thank the authors for providing this information, which will be helpful to include in future iterations of the Global Burden of Disease study to improve estimates of diseases requiring stem cell transplant.
Cowan AJ, Fitzmaurice C. Burden of Multiple Myeloma in Taiwan—Reply. JAMA Oncol. 2019;5(1):116. doi:10.1001/jamaoncol.2018.5533
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: